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Radioimmunoassay of rat leptin: sexual
dimorphism reversed from humans
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Bridgette Schoner,4 John E. Hale,4 and Mark L. Heiman4
Adipose tissue secretes leptin, which interacts with
receptors in the hypothalamus. In rodent models of
obesity, leptin increases metabolism and decreases food
intake, which helps to maintain normal body composi-
tion. Accurate and precise methods to quantitate circu-
lating leptin concentrations are needed for physiologi-
cal studies. We developed an RIA to measure leptin in
rat plasma, serum, or adipocyte culture fluids. The
working range of the assay, defined by the detection
limit and the highest calibrator, was 0.5–50 mg/L. Recov-
ery of 1.6–11.6 mg/L leptin added to serum was 92–103%.
The rat leptin RIA correlated well with a previously
developed mouse RIA when rat plasma was assayed
with both methods (r 5 0.94), but the mouse leptin assay
underestimated rat leptin in plasma. Within- and be-
tween-run CVs were 2.4% to 5.7%. Plasma leptin con-
centrations correlated directly with percentage of body
fat, and correlation improved when the results were
separated by gender (r 5 0.796, P <0.001 for males; r 5
0.710, P <0.001 for females). Leptin concentrations were
generally higher in male rats than in females; plasma
leptin increased 0.60 mg/L for each percentage of in-
crease in body fat for males but only 0.22 mg/L for
females. We conclude that rat serum/plasma leptin con-
centrations are accurately and precisely measured with
this new RIA.
In the few years since leptin was first characterized as the
product of the obese gene deficient in the ob/ob mouse [1],
considerable knowledge of leptin physiology has been
obtained. Mice given exogenous leptin have reduced food
intake and increased energy expenditure [2–4]. A recep-
tor, with several splice-variant forms, has been identified
and found in many rodent tissues (reviewed in [5]).
Considerable effort has been directed at understanding
the role of leptin in human obesity. Plasma concentrations
of leptin are increased in obese humans and strongly
correlate with the degree of adiposity as expressed by
percentage of body fat or body mass index [6–9]. Leptin
concentrations show a diurnal pattern, with nocturnal
concentrations increased in comparison with daytime
concentrations [10]. The diurnal pattern is disrupted by
fasting; leptin concentrations decrease dramatically in
response to fasting beyond the overnight period (.12 h)
[11–13]. Insulin homeostasis appears to influence leptin
metabolism, as evidenced by the increased leptin concen-
trations in insulin-resistant subjects [14], but acute
changes in insulin concentrations during several-hours-
long hyperinsulinemic clamps have minimal effect on
leptin plasma concentrations [15, 16]. The half-life of
circulating leptin (;25 min) is constant over a range of
adiposity [17]. Several studies have shown that plasma
leptin concentrations are appropriate for the degree of
subjects’ adiposity in anorexia nervosa [18], in the wasting
syndrome of HIV infection [19], and in lean long-distance
runners [20]. Strenuous exercise of a few hours has little
effect on plasma leptin concentrations, but prolonged
exercise decreases plasma leptin concentrations [20, 21].
Circulating leptin is bound to high-molecular-mass pro-
teins to various degrees in human and rodent plasma
[22, 23]. Several potential physiological roles for leptin
have been identified; some evidence exists that plasma
leptin concentrations may influence energy expenditure
in children [24] and predict weight gain in young women
[25]. Plasma leptin concentrations rose dramatically in
hamsters receiving exogenous endotoxin or cytokines,
suggesting a role for leptin in the anorexia of infection
[26]. Administration of exogenous leptin to mice hastened
female reproductive maturity and may have triggered
puberty [27]. Leptin also blunted the neuroendocrine
response to starvation, suggesting that leptin may modu-
late the physiological response to starvation [28].
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The rapid accumulation of knowledge concerning lep-
tin physiology has been importantly aided by the avail-
ability of a commercial RIA for human leptin [8]. Rodents,
particularly rats, are frequently used as models in endo-
crine and metabolic studies, but efforts to use these
species for studies of leptin physiology have been ham-
pered by the lack of a commercially available assay for rat
leptin. Rat leptin cross-reacts ,2% in the commercial
assay for human leptin (Gingerich, unpublished findings)
and, therefore, cannot be accurately measured with that
method. The sequence of rat leptin has been predicted
from the sequence of a cDNA [29], and rat leptin has been
successfully cloned for recombinant production [30].
These tools have allowed the generation of antibodies
specific for rat leptin in guinea pigs, which has provided,
along with recombinant rat leptin to formulate calibrators
and for labeling to make tracer, the critical components of
an RIA. This study examines the suitability of the newly
developed RIA for rat leptin for use in studies of leptin
physiology.
Materials and Methods
Animal studies. Sprague–Dawley, Long–Evans, Zucker,
and Fischer 344 rats of both sexes were purchased from
Harlan Sprague–Dawley. CD Sprague–Dawley rats were
obtained from Charles Rivers Laboratories. Rats were
housed in groups of five under 12 h of alternating light
(0600–1800 h) and dark (1800–0600 h) and allowed free
access to Purina rat chow and water for 2 weeks until
killed. The animal facility where these studies were per-
formed is a fully accredited, institutional member of the
American Association for the Accreditation of Laboratory
Animal Care and provides a committee that approved the
protocol used.
Method for body fat measurement. Rats were killed by
decapitation between 0700 and 0800 h, and trunk blood
was collected into 5-mL tubes containing 72 USP units of
sodium heparin (Vacutainer Tube; Becton Dickinson) that
were placed on ice until separation of plasma by centrif-
ugation at 4 °C. Plasma was stored at 220 °C for 30–45
days before analysis. Carcasses were placed into plastic
bags and frozen at 220 °C for 1–15 days and then shipped
to Covance Laboratories for measurement of total body
fat by Soxhlet extraction [31]. Briefly, the entire rat is
ground into fine particles and weighed into a cellulose
thimble containing sodium sulfate. The thimble is dried to
remove excess moisture and pentane is dripped through
the sample to remove the fat. The extract is then evapo-
rated, dried, and weighed.
Adipocyte isolation and culture. Epididymal fat deposits
were removed under aseptic conditions from adult male
Sprague–Dawley rats under halothane anesthesia. The
adipocytes were isolated by collagenase digestion accord-
ing to the Rodbell procedure [32] with minor modifica-
tions. Fat pads were minced with scissors in buffer, pH
7.4, containing 5 mmol/L d-glucose, 20 g/L bovine serum
albumin, 135 mmol/L NaCl, 2.2 mmol/L CaCl2, 1.25
mmol/L MgSO4, 0.45 mmol/L KH2PO4, 2.17 mmol/L
Na2HPO4, and 10 mmol/L HEPES and digested in the
same buffer in the presence of 2.5 mg/2 mL buffer per
gram of tissue type II collagenase (specific activity, 456
kU/g; Sigma Chemical Co.) at 37 °C with gentle shaking
at 60 cycles/min for 45 min. Isolated adipocytes were
separated from undigested tissue by filtration through a
400-mm nylon mesh and washed three times. The adipo-
cytes were resuspended in 5 mmol/L glucose culture
medium (Life Technologies, Inc.), supplemented with 50
mL/L fetal bovine serum, and then incubated for 30 min
at 37 °C before being plated in Matrigel-coated (Becton
Dickinson) culture plates (Fisher Scientific). One hundred
fifty microliters of the adipocyte suspension (2:1 ratio of
packed cells to media) was placed in each well with 2 mL
of culture medium supplemented with 50 mL/L fetal
bovine serum. The cells were maintained in an incubator
at 37 °C in CO2-enriched (60 mL/L) air. Samples (300 mL)
for leptin assay were collected after 24–96 h in culture.
Measurement of plasma/serum leptin. A new RIA was devel-
oped at Linco Research that readily detected leptin con-
centrations in rat plasma or serum. The assay is based on
a polyclonal antibody raised against recombinant rat
leptin in guinea pigs and on calibrators and 125I-labeled
tracer prepared from recombinant rat leptin. Calibrators
(0.5, 1, 2, 5, 10, 20, and 50 mg/L) or specimens were
pipetted in duplicate into tubes at 100 mL each and mixed
with anti-leptin antibody (100 mL). After incubation for
18–24 h at room temperature (disequilibrium assay for-
mat), 100 mL of 125I-tracer was added to each tube, and
incubation continued for another 18–24 h. Cold precipi-
tating antibody (1.0 mL; anti-guinea pig IgG, raised in
goats) was added to all tubes and incubated for 20 min at
4 °C to precipitate the antibody/leptin complex. Centrif-
ugation for 20 min at 2500g at 4 °C yielded visible pellets;
the supernatants were decanted, and the radioactivity in
the pellets was counted. Log values of calibrators were
plotted vs the calibrator-bound counts/zero calibrator-
bound counts (B/Bo) to generate a curve for calculation of
unknowns. Leptin was measured in plasma and culture
fluids with an assay specific for mouse leptin (Linco
Research), which has been evaluated previously [33].
Statistics. All quantitative results are reported as means 6
SD. Statistical significance was assessed in paired and un-
paired data by Student’s t-test; P ,0.05 was considered
significant. ANCOVA analysis was performed with STATA
software (Stata Corp.). Relationships between continuous
variables were evaluated by Spearman correlation.
Results
Limit of detection. The lowest measurable concentration of
leptin was determined by repeated within-run analysis of
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the 0.5 mg/L calibrator and of a buffer solution containing
no leptin. The ranges of the concentrations, expressed as
means 6 2 SD, determined for the two solutions were 0.37
to 0.77 mg/L and 20.12 to 0.32 mg/L, respectively; be-
cause these ranges do not overlap, the assay will differ-
entiate a specimen with a leptin concentration of 0.5 mg/L
from 0 in 95% of single measurements.
Analytical recovery. Various amounts of rat leptin were
added to a rat serum pool (endogenous leptin, 1.6 mg/L),
and the leptin concentration was determined in replicate
(n 5 4) assays. Recovery ranged from 92% to 103% at
added concentrations of 1.6 to 11.6 mg/L (Fig. 1).
Comparison with mouse-specific leptin assay. Leptin concen-
trations were determined in plasma from 12 adult male
Sprague–Dawley rats (weight range, 391–571 g) for com-
parison with results determined with a homologous assay
designed for measurement of mouse leptin (calibrators
and tracer made from recombinant mouse leptin, anti-
body made to mouse leptin; Fig. 2); this assay has been
evaluated previously [33]. On average, mouse assay re-
sults (4.2 6 2.0 mg/L) were 67% of the rat assay values
(6.3 6 3.4 mg/L), but linear regression analysis of the
results (mouse leptin assay 5 0.55 rat leptin assay 1 0.7
mg/L) showed that the correlation of the two assays was
highly significant (r 5 0.94, P ,0.001). Leptin concentra-
tions were also determined in 39 samples of media
collected from primary cultures of rat adipocytes, by both
assays (Fig. 3). Mouse assay results (1.9 6 1.2 g/L) were
86% of rat assay values (2.1 6 1.2 mg/L), and this
difference was due entirely to a set bias between the
assays (mouse leptin assay 5 1.028 rat leptin assay 2 0.3
mg/L). As with plasma, the correlation of the two meth-
ods was highly significant (r 5 0.97, P ,0.0001).
Linear dilution. Recovery of rat leptin on dilution was
assessed with four pools of Zucker rat plasma with initial
concentrations of 15.8, 16.0, 15.1, and 14.6 mg/L. Dilution
of these pools with buffer (1.33-, 2-, and 4-fold) resulted in
near 100% recovery of leptin concentrations at all dilu-
tions (Table 1).
Precision. Within- and between-assay precision was as-
sessed by repeated analysis of four rat serum pools
Fig. 1. Recovery of leptin added to a rat serum pool with an endoge-
nous leptin concentration of 1.6 mg/L.
Fig. 2. Leptin concentrations in plasma of 12 male Sprague–Dawley
rats measured with the rat leptin RIA, compared with results from a
mouse leptin RIA.
Fig. 3. Leptin concentrations in media from primary cultures of rat
adipocytes measured with the rat leptin RIA, compared with results
from a mouse leptin RIA.
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containing 1.6–11.6 mg/L leptin. CVs ranged from 2.4% to
4.6% within runs and from 4.8% to 5.7% between runs
(Table 2).
Stability. Stability of leptin in plasma was assessed in two
pools, one of which had been supplemented with recom-
binant rat leptin to raise the leptin concentration to ;6
mg/L. Leptin in both plasma pools was very stable for up
to 7 days at 4 °C or at room temperature, but the pool that
had been supplemented with recombinant leptin lost
marked amounts of leptin after 3 days at 37 °C (Table 3).
The other pool, with a lower concentration of entirely
endogenous leptin, was stable at 37 °C for 3 days. Five
freeze–thaw cycles had little effect on plasma leptin
concentrations (starting concentrations, 2.4 and 5.8 mg/L;
ending concentrations, 2.3 and 5.7 mg/L, respectively).
Two months of storage of six specimens, at concentrations
from 1.9 to 58.1 mg/L, at 220 °C was without effect on
measured leptin concentrations; the stored specimens had
105% 6 9% of the initial leptin concentrations.
Correlation of plasma leptin with percentage of body fat. Leptin
concentrations were measured in the plasma of 44 male
and 35 female Sprague–Dawley rats, ages 24 days to 3.5
months; after death, the body fat content of the rats was
determined by whole-body chemical analysis. There was
a significant correlation of plasma leptin values with
percentage of body fat for the combined population (r 5
0.636, P ,0.001), and correlation was improved by sepa-
rating the results according to gender (r 5 0.796, P ,0.001,
and r 5 0.710, P ,0.001, for males and females, respec-
tively; Fig. 4). Interestingly, males generally had higher
leptin concentrations in relation to body fat content than
females, with the distinction much more apparent at a
percentage of body fats .7% (Fig. 4). Leptin plasma
concentrations increased 0.60 mg/L for each percentage
of increase in body fat in males but only 0.22 mg/L for
each percentage of increase in body fat in females. By
ANCOVA the relationships of leptin concentration to
percentage of body fat were significantly different in
males vs females (P ,0.0001).
Plasma leptin and strain of rats. Typical plasma leptin
concentrations varied widely in different strains of rats
at age 2 months (Fig. 5). Obese Zucker rats had the
highest plasma leptin concentrations, and Sprague–
Dawley rats had the lowest. Where comparative data
were available, female rats tended to have lower leptin
concentrations than males, despite the fact that the fe-
males in this comparison were older (males, 2 months;
females, 3 months).
Discussion
This new RIA provides accurate and precise analysis of
rat serum/plasma leptin. The working range of the assay,
defined by the detection limit of 0.5 mg/L and the
concentration of the highest calibrator (50 mg/L), effec-
tively covers the range of plasma leptin concentrations
seen in both lean, young animals and those in adult rats of
strains studied as models of genetic obesity. Leptin con-
Table 1. Plasma dilution linearity of rat leptin RIA.
Sample volumea, mL Measured/expected, %b
100 100c
75 103 6 5
50 101 6 5
25 96 6 7
a Sample volume made up to 100 mL by the addition of buffer.
b Mean of results for four plasma specimens, after conversion to a percentage
of starting concentration. All dilutions were prepared in duplicate.
c Starting concentrations were defined as 100%.
Table 2. Variation within- and between-assays.
Sample Mean, mg/La
CV, %
Within-Run Between-Run
1 1.6 2.4 4.8
2 3.3 4.1 3.0
3 6.8 2.0 5.7
4 11.6 4.6 5.7
a From 10 replicates of each serum sample in four separate assays.
Table 3. Effect of storage at various temperatures on rat
plasma leptin.
Temp
Leptin concentration (mg/L)a
Day 0 Day 1 Day 2 Day 3 Day 5 Day 7
4 °C 2.4 2.3 2.4 2.0 2.3 2.1
5.8 5.9 6.1 6.3 6.2 6.2
Ambient 2.4 2.1 2.3 2.3 2.5 2.2
5.8 6.1 6.2 6.3 5.7 5.4
37 °C 1.0 0.9 1.0 1.1
5.8 5.7 4.5 2.7
a Each result is the mean of leptin determinations in duplicate aliquots.
Fig. 4. Correlation of plasma leptin concentrations with percentage of
body fat in 44 male (F) and 35 female (E) Sprague–Dawley rats.
568 Landt et al.: Rat leptin RIA
centrations measured with the new procedure increased
systematically and directly with percent body fat; because
leptin production and plasma concentrations are known
to increase with increases in adiposity in humans and
mice [6–9, 33], it is important that the assay accurately
reflects the same relationship in rats.
Plasma leptin concentrations had been measured pre-
viously in only humans and mice, and measurements in
mice sometimes used methods that generated semiquan-
titative results, such as immunostaining of Western blots
[6–8, 33–36]. Nevertheless, the available data suggest that
plasma leptin concentrations are very similar in humans
and rats after the degree of adiposity of the subjects is
taken into account. Reported plasma concentrations in
lean humans (,15% body fat in men and ,25% in
women) [37] were 1–16 mg/L [6–9]. Plasma concentra-
tions in the rats in this study were lower (0.5–6 mg/L) but
appropriate for their low percentage of body fat com-
pared with humans and were similar to concentrations in
humans with a low percentage of body fat due to anorexia
nervosa [18] or the wasting syndrome of HIV infection
[19]. Plasma leptin concentrations in mice are 2–11 mg/L,
as determined by RIA [33, 34].
As in humans, male and female rats have different
relationships of plasma leptin to percentage of body fat;
but in contrast to humans, plasma leptin concentrations in
females increase at a lower rate with increasing adiposity
than in males. Several studies have shown that leptin
concentrations rise 0.4–3 times as fast in women as in
men, as the percentage of body fat increases [38–41]. The
basis of the higher plasma leptin concentrations in women
is not known, but evidence suggests that the dimorphism
may be associated with puberty, because leptin concen-
trations in girls but not boys rise during puberty [42].
However, leptin concentrations do not decrease with
menopause, which suggests that reproductive hormone
status is not responsible for the sexual dimorphism [38].
Why rats and humans differ with respect to the effect of
sexual dimorphism is not known, but the two species
differ dramatically with respect to the sexual dimorphism
of body fat content. Whereas human females have higher
body fat content than males, the opposite is true for rats
[43]. The dichotomy in the sexual dimorphism of leptin in
rats compared with humans may be related to differences
in the distribution and extent of fat stores.
Leptin circulates in both rodents and humans in free
and protein-bound forms [22, 23]. The binding proteins
have not been fully characterized, but they are heteroge-
neous, and a portion of the binding may involve disulfide
linkages [22]. The presence of multiple forms of leptin in
plasma raises the possibility that an RIA may variably
measure the forms present. The human leptin RIA ap-
pears to effectively measure all forms present in human
plasma, based on comparison of RIA results with quanti-
tation on Western blots, which likely detects all forms
because of denaturation of all noncovalent binding and
reduction of disulfide bonds [8]. Comparable experiments
to examine the efficacy of the rat leptin RIA to measure all
circulating forms are not possible, because the very low
concentrations of leptin in rat plasma defeat the sensitiv-
ity of the Western blot method. Characterization of the
ability of the rat RIA to quantitate the various forms will
depend on the development of methods for the physical
separation of rat plasma leptin forms.
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